Randomized Clinical Trial
Copyright ©The Author(s) 2018.
World J Gastroenterol. Sep 21, 2018; 24(35): 4077-4085
Published online Sep 21, 2018. doi: 10.3748/wjg.v24.i35.4077
Table 1 Characteristics of patients scheduled to undergo endoscopic submucosal dissection between those with or without endoclip
TotalConventional groupClip-flap groupP value
Number (n)1045549
Age (yr)70.1 ± 8.369.0 ± 9.571.2 ± 6.50.17
Sex (male : female)80:2442:1338:110.89
Body weight (kg)59.0 ± 11.258.0 ± 11.060.2 ± 11.50.34
BMI (kg/m2)22.2 ± 3.121.7 ± 2.922.8 ± 3.30.08
Drugs, n (%)
Anticoagulants19 (18.3)11(20.0)8 (16.3)0.63
Antihypertensive dugs56 (53.8)25 (45.5)31 (63.3)0.07
Oral hypoglycemics16 (15.4)8 (14.5)8 (16.3)0.80
Cholesterol-lowering agents25 (24.0)13 (23.6)12 (24.5)0.91
H. pylori infection (positive)36 (34.6)16 (29.1)20 (40.8)0.21
Hemodialysis, n (%)0 (0)0 (0)0 (0)-
Kyoto classification of gastric mucosa
Atrophy (A0:A1:A2)3:7:942:4:491:3:450.86
Intestinal metaplasia (IM0:IM1:IM2)8:36:605:15:353:21:250.24
Diffuse redness (DR0:DR1 :DR2)47:24:3326:13:1621:11:170.83
Tumor
Histological diagnosis (adenoma/cancer)9/956/493/460.39
Differentiation (tub1 + tub2/por + sig)92/348/144/20.52
Depth (m/sm)82/1342/740/60.86
Location (upper third/middle/lower)10/37/577/20/283/17/290.47
Major axis of tumor (mm)18.5 ± 13.417.5 ± 11.819.7 ± 15.10.39
ESD
Procedure time (min)72.6 ± 49.570.8 ± 46.274.7 ± 53.30.69
Area of resected specimen (mm2)962 1 ± 896.2884.6 ± 792.11006.4 ± 1004.80.49
En bloc resection rate (n, %)104 (100)55 (100)49 (100)-
Curative endoscopic resection rate (n, %)94 (90.4)50 (90.9)44 (89.8)0.85
Coagulation of vessels at 2nd look (n, %)28 (26.9)16 (29.6)12 (25.0)0.60
Delayed bleeding (n, %)4 (3.8)3 (5.5)1 (2.0)0.37
Perforation (n, %)2 (1.9)1 (1.8)1 (2.0)0.93
Operator
Procedure times (< 50 cases)8343400.66